Patents by Inventor Ali Ellebedy

Ali Ellebedy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230348585
    Abstract: Methods for treating or reducing the severity of a viral infection such as SARS-CoV-2 are provided, which include the administration of a cortisol antagonist preferably in combination with an IL-6 antagonist.
    Type: Application
    Filed: May 5, 2021
    Publication date: November 2, 2023
    Inventors: Paul THOMAS, Jeremy Chase CRAWFORD, Emma Kaitlynn SLIGER, Aisha SOUQUETTE, Ali ELLEBEDY, Philip MUDD
  • Publication number: 20230077716
    Abstract: The present invention relates to antibodies or antigen-binding fragments that are useful for treating influenza B viruses. The present invention also relates to various pharmaceutical compositions and methods of treating influenza using the antibodies or antigen-binding fragments.
    Type: Application
    Filed: February 5, 2021
    Publication date: March 16, 2023
    Inventor: Ali Ellebedy
  • Publication number: 20220289827
    Abstract: The present invention relates to antibodies or antigen-binding fragments that are useful for treating coronavirus infections (e.g., COVID-19 caused by SARS-CoV-2). The present invention also relates to various pharmaceutical compositions and methods of treating coronavirus using the antibodies or antigen-binding fragments.
    Type: Application
    Filed: March 11, 2022
    Publication date: September 15, 2022
    Inventor: Ali Ellebedy
  • Publication number: 20220242935
    Abstract: The present invention relates to antibodies against influenza neuraminidase, compositions containing the antibodies and methods of using the antibodies.
    Type: Application
    Filed: May 29, 2020
    Publication date: August 4, 2022
    Applicants: Washington University, Icahn School of Medicine at Mount Sinai, The Scripps Research Institute
    Inventors: Ali Ellebedy, Florian Krammer, Ian Wilson
  • Publication number: 20220017604
    Abstract: The present invention relates to antibodies or antigen-binding fragments that are useful for treating coronavirus infections (e.g., COVID-19 caused by SARS-CoV-2). The present invention also relates to various pharmaceutical compositions and methods of treating coronavirus using the antibodies or antigen-binding fragments.
    Type: Application
    Filed: April 16, 2021
    Publication date: January 20, 2022
    Applicant: Washington University
    Inventors: Ali Ellebedy, Aaron Schmitz, Jackson Turner, Wafaa Al Soussi, Michael Diamond, Daved Fremont, James Brett Case, Haiyan Zhao, Adrianus Boon, Sean Whelan, Andrew McCluskey, Christopher Negron